Industry veteran John Bailey, who served a decade as director of the US Food and Drug Administration’s Office of Cosmetics and Colors, is confident there is a way to meaningfully update federal cosmetics regulations to benefit all stakeholders.
The Senate’s current proposal in the FDA Safety and Landmark Advancements (FDASLA) Act, S. 4348, is not it, he...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?